Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

At the end of the day, all that matters is the Phase 2b trial data reading. You, me, the rest of us, we don't need to worry about any other logistics. That's because if the trial data is positive, this will sky rocket out of control. Sure, Phase 3 would happen. But it wouldn't matter, because we already got safety approval, we know its safe. So if phase 2 shows it works, this will explode and they will have deals coming at them from every angle from big pharma